Pharmacological treatments for rhinosinusitis

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 3, 2002, Pages 305-313

  Taghizadeh, Farhan ^a   Hadley, James A ^a   Osguthorpe, J David ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Acute bacterial sinusitis; Bacterial isolates; Chronic sinusitis; Guidelines; Infection; Resistant bacteria; Rhinosinusitis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; DECONGESTIVE AGENT; GUAIFENESIN; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LORACARBEF; MACROLIDE; MONTELUKAST; MUCOLYTIC AGENT; PENICILLIN DERIVATIVE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNINDEXED DRUG; ZAFIRLUKAST;

ADULT; ALLERGIC RHINITIS; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CHILD; CHRONICITY; CONTROLLED STUDY; COST OF ILLNESS; DRUG BIOAVAILABILITY; DRUG EFFICACY; GENERAL PRACTITIONER; HAEMOPHILUS INFLUENZAE; HUMAN; INFLAMMATION; MORAXELLA CATARRHALIS; NONHUMAN; RHINOSINUSITIS; SEDATION; SIDE EFFECT; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; TACHYCARDIA; VIRUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; GUIDELINES; HUMANS; MYCOSES; RHINITIS; RHINITIS, ALLERGIC, PERENNIAL; SINUSITIS;

EID: 0036197241     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.3.305     Document Type: Article

References (58)

1. Sinusitis: Bench to bedside: Current findings
2. Trends in antimicrobial drug prescribing among office-based physicians in the United States
3. Acute community acquired sinusitis
4. Sinusitis: Current concepts and management
5. Management of chronic sinusitis
6. Adult rhinosinusitis defined
7. Histology and histomorphometry of ethmoid bone in chronic sinusitis
8. Chronic sinusitis
9. Sinusitis in an allergist's office: Analysis of 200 consecutive cases
10. Chronic sinusitis among paediatric patients with chronic respiratory complaints
11. Sinusitis in an allergist's office: Analysis of 200 consecutive cases
12. Sinusitis: Bench to bedside. Current findings, future directions
13. The diagnosis and incidence of allergic fungal sinusitis
14. Inflammatory mechanisms in chronic sinusitis
15. Medical management of sinusitis
16. Evidence for distinct cytokine expression in allergic versus non-allergic chronic sinusitis
17. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP)
18. Nasal polyps and immunoglobulin E (IgE)
19. Bacteriology of maxillary sinusitis in relation to character of inflammation and prior treatment
20. Microbiology and management of sinusitis
21. The microbial aetiology and antimicrobial therapy of adults with acute community-acquired sinusitis: A 15-year experience at the University of Virginia and review of other selected studies
22. Antimicrobial treatment for acute bacterial rhinosinusitis
23. Bacteriology of the ethmoid bullae in children with chronic sinusitis
24. What is the bacteriology of chronic sinusitis in adults?
25. Bacteriologic features of chronic sinusitis in children
26. Microbiology and management of chronic maxillary sinusitis
27. Microbiology of chronic maxillary sinusitis in adults: Isolated aerobic and anaerobic bacteria and their susceptibility to twenty antibiotics
28. Bacteriology and β-lactamase activity in acute and chronic maxillary sinusitis
29. Antimicrobial management of chronic sinusitis in children
30. Evaluation of the microbiology of chronic ethmoid sinusitis
31. Microbiology of the middle meatus: A comparison between normal adults and children
32. Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis
33. Clinical relevance of pharmacokinetic/pharmacodynamic properties of antimicrobials for therapy of drug resistant Streptococcus pneumoniae infection
34. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US Surveillance Study
35. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to oral agents: Results of a 1998 US outpatient surveillance study
36. Antimicrobial management of chronic sinusitis in children
37. Clinical relevance of pharmacokinetic/pharmacodynamic properties of antimicrobials for therapy of drug resistant Streptococcus pneumoniae infection
38. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US Surveillance Study
39. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to oral agents: Results of a 1998 US outpatient surveillance study
40. Bacteriologic efficacious of oral azithromycin and oral cefaclor in treatment of acute Otitis media in infants and young children
41. Breakthrough sepsis in macrolide resistant pneumococcal infection
42. New antibiotics in pulmonary critical care medicine, focus on advanced generation quinolones and cephalasporins
43. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
44. Adjuncts to medical management of sinusitis
45. Chronic sinusitis
46. Treatment with hypertonic saline versus normal saline nasal wash of paediatric chronic sinusitis
47. Mucociliary clearance and buffered hypertonic saline solution
48. Extended use of topical nasal decongestants
49. The medical management of rhinosinusitis
50. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children
51. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate
52. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray
53. Intranasal steroids and septum perforation - An overlooked complication? A description of the course of events and a discussion of the causes
54. Effect of Intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression and proinflammatory cytokine mRNA in nasal polyp disease
55. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging
56. Chronic sinusitis: Relationship of computed tomographic findings to allergy, asthma and eosinophilia